JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Kealy D, Ellerington R, Bansal S, Medeiros JJF, Hawley CA, Zeng AGX, Lukaszonek J, West KA, Sinha AD, Caalim G, Gawne RT, Pope J, Ferreira BL, Blacknell NM, Drylie B, Chatzigerou J, Khoo HM, Wilkinson AC, Fielding AK, Wang G, Psaila B, Kent DG, Hitchcock IS, Holding AN, Mason AS, Gupta V, Dick JE, Bridge KS

Open source

DOI: 10.1038/s41375-025-02843-9
Published: 2026 Mar
Container: Leukemia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-025-02843-9,
  title = {JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.},
  author = {Kealy D and Ellerington R and Bansal S and Medeiros JJF and Hawley CA and Zeng AGX and Lukaszonek J and West KA and Sinha AD and Caalim G and Gawne RT and Pope J and Ferreira BL and Blacknell NM and Drylie B and Chatzigerou J and Khoo HM and Wilkinson AC and Fielding AK and Wang G and Psaila B and Kent DG and Hitchcock IS and Holding AN and Mason AS and Gupta V and Dick JE and Bridge KS},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-025-02843-9},
  url = {https://doi.org/10.1038/s41375-025-02843-9}
}

RIS

TY  - JOUR
TI  - JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.
AU  - Kealy D
AU  - Ellerington R
AU  - Bansal S
AU  - Medeiros JJF
AU  - Hawley CA
AU  - Zeng AGX
AU  - Lukaszonek J
AU  - West KA
AU  - Sinha AD
AU  - Caalim G
AU  - Gawne RT
AU  - Pope J
AU  - Ferreira BL
AU  - Blacknell NM
AU  - Drylie B
AU  - Chatzigerou J
AU  - Khoo HM
AU  - Wilkinson AC
AU  - Fielding AK
AU  - Wang G
AU  - Psaila B
AU  - Kent DG
AU  - Hitchcock IS
AU  - Holding AN
AU  - Mason AS
AU  - Gupta V
AU  - Dick JE
AU  - Bridge KS
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-025-02843-9
UR  - https://doi.org/10.1038/s41375-025-02843-9
ER  -

APA

D, K., R, E., S, B., JJF, M., CA, H., AGX, Z., J, L., KA, W., AD, S., G, C., RT, G., J, P., BL, F., NM, B., B, D., J, C., HM, K., AC, W., AK, F., G, W., B, P., DG, K., IS, H., AN, H., AS, M., V, G., JE, D., & KS, B. (2026). JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.. Leukemia. https://doi.org/10.1038/s41375-025-02843-9

Source records

pubmed · retrieved 2026-09-26T13:30:10.685Z
europe-pmc · retrieved 2026-09-26T13:30:10.696Z